Mustang Bio
Price & Volume
Stats
See moreOpen | $1.79 |
Previous Close | $1.77 |
Day Range | $1.60-$1.79 |
52W Range | $0.95-$18.50 |
Market Cap | $12.5M |
Shares Short | 82,705 |
Financials
See moreRevenue (12 Mos) | -$50,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $1.99 |
News
See moreYahoo Finance • 26 days ago
7 Biotech Stocks Trading At 52-Week Highs - Can The Rally Continue?
Yahoo Finance • 3 months ago
Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies
Yahoo Finance • 3 months ago
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Yahoo Finance • 7 months ago
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
About
CEO | Dr. Manuel Litchman M.D. |
CFO | Dr. Manuel Litchman M.D. |
Address | 95 Sawyer Road, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6 |
